Back to Search
Start Over
A leopard can't change its spots: can a T790M mutation-positive cancer change its spots after epidermal growth factor receptor-tyrosine kinase inhibitor therapy?
- Source :
- Journal of thoracic disease. 10(Suppl 33)
- Publication Year :
- 2019
-
Abstract
- Drug therapies for non-small cell lung cancer (NSCLC) have greatly progressed in recent years. Especially, the identification of epidermal growth factor receptor ( EGFR ) mutation has transformed the management of patients with EGFR-mutant NSCLC, who are sensitive to EGFR tyrosine kinase inhibitor (EGFR-TKI).
- Subjects :
- Pulmonary and Respiratory Medicine
Mutation
biology
business.industry
Cancer
medicine.disease_cause
medicine.disease
respiratory tract diseases
T790M
Editorial
medicine
Cancer research
biology.protein
Non small cell
Epidermal growth factor receptor
business
Egfr tyrosine kinase
Epidermal growth factor receptor tyrosine kinase
Subjects
Details
- ISSN :
- 20721439
- Volume :
- 10
- Issue :
- Suppl 33
- Database :
- OpenAIRE
- Journal :
- Journal of thoracic disease
- Accession number :
- edsair.doi.dedup.....638b6ce05513e6e4046bdb79d67ad967